These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 10543631)

  • 1. Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy.
    Bitsch A; Bruhn H; Vougioukas V; Stringaris A; Lassmann H; Frahm J; Brück W
    AJNR Am J Neuroradiol; 1999 Oct; 20(9):1619-27. PubMed ID: 10543631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axonal damage but no increased glial cell activity in the normal-appearing white matter of patients with clinically isolated syndromes suggestive of multiple sclerosis using high-field magnetic resonance spectroscopy.
    Wattjes MP; Harzheim M; Lutterbey GG; Klotz L; Schild HH; Träber F
    AJNR Am J Neuroradiol; 2007 Sep; 28(8):1517-22. PubMed ID: 17846203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study.
    Simone IL; Tortorella C; Federico F; Liguori M; Lucivero V; Giannini P; Carrara D; Bellacosa A; Livrea P
    J Neurol Sci; 2001 Jan; 182(2):143-50. PubMed ID: 11137520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative proton magnetic resonance spectroscopy of focal brain lesions.
    Wilken B; Dechent P; Herms J; Maxton C; Markakis E; Hanefeld F; Frahm J
    Pediatr Neurol; 2000 Jul; 23(1):22-31. PubMed ID: 10963966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The contribution of (1)H-magnetic resonance spectroscopy in defining the pathophysiology of multiple sclerosis.
    Simone IL; Tortorella C; Federico F
    Ital J Neurol Sci; 1999; 20(5 Suppl):S241-5. PubMed ID: 10662956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolite findings in tumefactive demyelinating lesions utilizing short echo time proton magnetic resonance spectroscopy.
    Cianfoni A; Niku S; Imbesi SG
    AJNR Am J Neuroradiol; 2007 Feb; 28(2):272-7. PubMed ID: 17296993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton MR spectroscopy and magnetization transfer ratio in multiple sclerosis: correlative findings of active versus irreversible plaque disease.
    Kimura H; Grossman RI; Lenkinski RE; Gonzalez-Scarano F
    AJNR Am J Neuroradiol; 1996 Sep; 17(8):1539-47. PubMed ID: 8883654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conventional and advanced magnetic resonance imaging in tumefactive demyelination.
    Saini J; Chatterjee S; Thomas B; Kesavadas C
    Acta Radiol; 2011 Dec; 52(10):1159-68. PubMed ID: 22025739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of citrullinated myelin by 1H-MR spectroscopy in early-onset multiple sclerosis.
    Oguz KK; Kurne A; Aksu AO; Karabulut E; Serdaroglu A; Teber S; Haspolat S; Senbil N; Kurul S; Anlar B
    AJNR Am J Neuroradiol; 2009 Apr; 30(4):716-21. PubMed ID: 19147724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High field MR imaging and 1H-MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis: correlation between metabolic alterations and diagnostic MR imaging criteria.
    Wattjes MP; Harzheim M; Lutterbey GG; Bogdanow M; Schild HH; Träber F
    J Neurol; 2008 Jan; 255(1):56-63. PubMed ID: 18080854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of proton MR spectroscopy for differentiating typical and atypical primary central nervous system lymphomas from tumefactive demyelinating lesions.
    Lu SS; Kim SJ; Kim HS; Choi CG; Lim YM; Kim EJ; Kim DY; Cho SH
    AJNR Am J Neuroradiol; 2014 Feb; 35(2):270-7. PubMed ID: 23928144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of spectroscopy and magnetization transfer imaging in the evaluation of demyelinating lesions and normal appearing white matter in multiple sclerosis.
    Hiehle JF; Lenkinski RE; Grossman RI; Dousset V; Ramer KN; Schnall MD; Cohen JA; Gonzalez-Scarano F
    Magn Reson Med; 1994 Sep; 32(3):285-93. PubMed ID: 7984060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton MR spectroscopy and MR imaging in acute and chronic multiple sclerosis--ringlike appearances in acute plaques.
    Landtblom AM; Sjöqvist L; Söderfeldt B; Nyland H; Thuomas KA
    Acta Radiol; 1996 May; 37(3 Pt 1):278-87. PubMed ID: 8845254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benign versus secondary-progressive multiple sclerosis: the potential role of proton MR spectroscopy in defining the nature of disability.
    Falini A; Calabrese G; Filippi M; Origgi D; Lipari S; Colombo B; Comi G; Scotti G
    AJNR Am J Neuroradiol; 1998 Feb; 19(2):223-9. PubMed ID: 9504469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial diffusion-weighted MR imaging and proton MR spectroscopy of acute large demyelinating brain lesions: case report.
    Rovira A; Pericot I; Alonso J; Rio J; Grivé E; Montalban X
    AJNR Am J Neuroradiol; 2002; 23(6):989-94. PubMed ID: 12063231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cuprizone-induced demyelination and demyelination-associated inflammation result in different proton magnetic resonance metabolite spectra.
    Praet J; Orije J; Kara F; Guglielmetti C; Santermans E; Daans J; Hens N; Verhoye M; Berneman Z; Ponsaerts P; Van der Linden A
    NMR Biomed; 2015 Apr; 28(4):505-13. PubMed ID: 25802215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques.
    Arnold DL; Matthews PM; Francis GS; O'Connor J; Antel JP
    Ann Neurol; 1992 Mar; 31(3):235-41. PubMed ID: 1637131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton MRS profile of cerebral metabolic abnormalities in Krabbe disease.
    Brockmann K; Dechent P; Wilken B; Rusch O; Frahm J; Hanefeld F
    Neurology; 2003 Mar; 60(5):819-25. PubMed ID: 12629240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis.
    Fernando KT; McLean MA; Chard DT; MacManus DG; Dalton CM; Miszkiel KA; Gordon RM; Plant GT; Thompson AJ; Miller DH
    Brain; 2004 Jun; 127(Pt 6):1361-9. PubMed ID: 15128615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Proton magnetic-resonance spectroscopy in remitting and secondary-progressive multiple sclerosis].
    Pozdniakov AV; Tiutin LA; Bisaga GN; Odinak MM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(4):36-9. PubMed ID: 11490432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.